Dabrafenib (Tafinlar)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Dabrafenib (Tafinlar), covering 2015-12-11 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 1]